Previous 10 | Next 10 |
MINNEAPOLIS, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announces that the independent Data Safety Monitoring Board (DSMB) of the Phase 3...
2023-11-22 17:12:00 ET More on Panbela Therapeutics Seeking Alpha’s Quant Rating on Panbela Therapeutics Historical earnings data for Panbela Therapeutics Financial information for Panbela Therapeutics For further details see: Panbela Therapeutics ...
2023-11-10 22:15:08 ET Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Conference Call November 09, 2023, 04:30 PM ET Company Participants James Carbonara - IR Jennifer Simpson - CEO Sue Horvath - CFO Conference Call Participants Jonathan Aschoff -...
2023-11-09 16:43:27 ET More on Panbela Therapeutics Seeking Alpha’s Quant Rating on Panbela Therapeutics Historical earnings data for Panbela Therapeutics Financial information for Panbela Therapeutics For further details see: Panbela Therapeutics ...
MINNEAPOLIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Panbela Therapeutics Inc. (PBLA) is expected to report $-2.06 for Q3 2023
MINNEAPOLIS, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced it has entered into agreements with certa...
2023-11-02 12:16:20 ET DENVER, Colo., Nov. 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Palantir Technologies Inc (NYSE: PLTR), Panbela Therapeutics Inc (NASDAQ: PBLA), Joby Aviation Inc (NYS...
2023-11-02 10:00:21 ET DENVER, Colo., Nov. 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Palantir Technologies Inc (NYSE: PLTR), Panbela Therapeutics Inc (NASDAQ: PBLA), Joby Aviation Inc (NYSE: JOBY...
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
Panbela Therapeutics Inc Com Website:
DSMB Recommends Continuation without Modification for Third Time Safety Review Included 395 Patients Interim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low Event Rate Suggests Potential for Prolonged Survival Rapid Enrollment P...
MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announces an oral presentation at the Digestive Disease Week (DDW) conference,...
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...